Advertisement

Purified Chick Embryo Cell (PCEC) Rabies Vaccine for Human Use — Laboratory Data

  • R. Barth
  • U. Bijok
  • H. Gruschkau
  • O. Jaeger
  • E. Weinmann
Conference paper

Summary

In order to overcome the difficulties and risks involved in production of HDC rabies vaccine for human use, a new tissue culture rabies vaccine for use in man has been developed. The Flury LEP-C25 strain was propagated in primary chick embryo cells (CEC), the tissue culture fluid was purified and concentrated by continuous density gradient centrifugation and inactivated by betapropiolactone. The antigen concentrates were tested by the modified antibody binding test and the vaccine adjusted to contain >2.5IU per dose. It was imposed that this vaccine should match the high standards of potency and tolerability achieved in the field by the HDC-vaccine. Therefore, this vaccine had to undergo numerous laboratory trials before clinical tests in man were considered.

Keywords

Rabies Virus Protection Rate Rabies Vaccine Human Diploid Cell Antibody Induction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wiktor TJ, Plotkin SA, Koprowski H (1978) Development and clinical trials of the new human rabies vaccine of tissue culture (human diploid cell) origin. Develop biol Standard 40:3–9Google Scholar
  2. 2.
    Barth R, Groß-Albenhausen E, Jaeger O, Milcke L (1981) The antibody binding test, a useful method for quantitative determination of inactivated rabies virus antigen. J biol Stand 9:81–89PubMedCrossRefGoogle Scholar
  3. 3.
    Barth R, Gruschkau H, Jaeger O, Milcke L (1982) Purification, concentration and evaluation of rabies virus antigen. Comp Immun Microbiol Infect Dis 5:211–216CrossRefGoogle Scholar
  4. 4.
    Barth R, Gruschkau H, Bijok U, Hilfenhaus J, Hinz J, Milcke L, Moser H, Jaeger O, Ronneberger H, Weinmann E (in press) A new inactivated tissue culture rabies vaccine for use in man. Evaluation by laboratory tests. J biol StandGoogle Scholar
  5. 5.
    Rosanoff EJ (1979) The potency of rabies vaccines as determined by the induction of antibody in mice. J Biol Stand 7:1–7PubMedCrossRefGoogle Scholar
  6. 6.
    Baer GM, Yager Pamela (1977) A mouse model for post-exposure rabies prophylaxis: the comparative efficacy of two vaccines and of antiserum administration. J Gen Virology 36:51–58CrossRefGoogle Scholar
  7. 7.
    Mifune K, Shighijo A, Makino Y, Takeughi E, Aymada A, Sakamoto K (1980) A mouse model for the pathogenesis and postexposure prophylaxis of rabies. Microbiol Immunol 24(9): 835–845PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin, Heidelberg 1985

Authors and Affiliations

  • R. Barth
  • U. Bijok
  • H. Gruschkau
  • O. Jaeger
  • E. Weinmann
    • 1
  1. 1.Behring InstituteMarburg (Lahn)Germany

Personalised recommendations